![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » FDA Grants 510(k) Clearance to Cepheid for Xpert Flu+RSV Test
FDA Grants 510(k) Clearance to Cepheid for Xpert Flu+RSV Test
The FDA has awarded Cepheid 510(k) clearance and Clinical Laboratory Improvement Amendments waiver for its Xpert Flu+RSV Xpress test for use on the GeneXpert Xpress System.
The GeneXpert Xpress System is the first in a series of reference-quality molecular tests that Cepheid plans to deliver over the next several years.
The Xpert Flu+RSV Xpress test features high-level multiplexing, redundant target segments and extended coverage for human and avian influenza strain, according to Cepheid's Chief Medical and Technology Officer David Persing. — Michael Cipriano
Upcoming Events
-
11Jul
-
18Jul
-
21Oct